Literature DB >> 14677038

Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies: comment on the article by Sairam et al.

Doruk Erkan, Yusuf Yazici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14677038     DOI： 10.1007/s10067-003-0777-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  3 in total

Review 1.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

Authors:  W A Wilson; A E Gharavi; T Koike; M D Lockshin; D W Branch; J C Piette; R Brey; R Derksen; E N Harris; G R Hughes; D A Triplett; M A Khamashta
Journal:  Arthritis Rheum       Date:  1999-07

2.  Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies.

Authors:  S Sairam; B A Baethge; T McNearney
Journal:  Clin Rheumatol       Date:  2003-02       Impact factor: 2.980

3.  A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.

Authors:  D Erkan; Y Yazici; M G Peterson; L Sammaritano; M D Lockshin
Journal:  Rheumatology (Oxford)       Date:  2002-08       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.